Thromb Haemost 1976; 36(03): 495-502
DOI: 10.1055/s-0038-1648068
Original Article
Schattauer GmbH

Severe Antithrombin III Deficiency in an Infant Associated with Multiple Arterial and Venous Thromboses

Geoffrey Mendelsohn
*   Department of Histopathology, School of Pathology of The University of the Witwatersrand and The South African Institute for Medical Research, Baragwanath Hospital and The University of the Witwatersrand, Johannesburg, South Africa
,
Edward D. Gomperts
**   Department of Haematology, School of Pathology of The University of the Witwatersrand and The South African Institute for Medical Research, Baragwanath Hospital and The University of the Witwatersrand, Johannesburg, South Africa
,
Dennis Gurwitz
***   Department of Paediatrics, Baragwanath Hospital and The University of the Witwatersrand, Johannesburg, South Africa
› Author Affiliations
Further Information

Publication History

Received 02 October 1975

Accepted 20 July 1976

Publication Date:
03 July 2018 (online)

Summary

Inherited antithrombin III (AT-II, heparin cofactor) deficiency is a rare condition, presenting with thrombotic disease in adult life. This paper reports an 8 months old South African Black male infant with multiple large vessel venous and arterial thromboses, and E. coli septicaemia. This was associated with an extremely low plasma AT-II level. Micronodular cirrhosis and intracytoplasmic hyaline globules in the liver cells were present. These globules were eosinophilic, and PAS-positive after diastase. They measured approximately 5 μ to 30 μ in diameter, occurred singly in the liver cells and were located mainly in the periportal areas. The histological findings in the liver are similar to those observed in α1-antitrypsin (AAT) deficiency in which the intracytoplasmic globules represent accumulation of altered AAT. Immunochemical studies carried out on formalin fixed tissue failed to detect cross reaction material with anti-α1 antitrypsin or anti-AT III antiserum. This is the first case report of AT-III deficiency presenting in infancy. It is also the first case associated with distinctive liver pathology.

The available data presented are insufficient to distinguish between an inborn defect and acquired causes of the severely depressed AT-III plasma level and the distinctive liver pathology.

* Current address: Department of Pathology, The John Hopkins Hospital, Baltimore, Md. 21205, U.S.A.


 
  • References

  • 1 Abilgaard U. 1968; Highly purified antithrombin III with heparin cofactor activity prepared by disc electrophoresis. Scandinavian Journal Clinical and Laboratory Investigation 21: 89.
  • 2 Abildgaard U, Fagerhol M. K, Egeberg O. 1970; Comparison of progressive antithrombin activity and the concentrations of three thrombin inhibitors in human plasma. Scandinavian Journal Clinical and Laboratory Investigation 26: 349.
  • 3 Becker B. J. P. 1961; The nature of alcoholic hyaline. A histochemical study. Laboratory Investigation 10: 527.
  • 4 Biggs R. 1972. Human Blood Coagulation, Haemostasis and Thrombosis. Blackwell Scientific Publications; Oxford:
  • 5 Cohen C. 1975; Liver pathology in alpha1-antitrypsin deficiency. A review. South African Medical Journal 49: 849.
  • 6 Dekker A, Krause J. R. 1973; Hyaline globules in human neoplasms. A report of 3 autopsy cases. Archives of Pathology 95: 178.
  • 7 De Lellis R. A, Balogh J, Merk F. B, Chirife A. M. 1972; Distinctive hepatic cell globules in adult alpha1-antitrypsin deficiency. A histochemical immunohistochemical and ultrastructural study. Archives of Pathology 94: 308.
  • 8 Doniach I, Weinbren K. 1952; The development of inclusion bodies in the cells of the rat’s liver after partial hepatectomy. British Journal of Experimental Pathology 33: 499.
  • 9 Ellis B. C, Stransky A. 1961; A quick and accurate method for the determination of fibrinogen in plasma. Journal of Laboratory and Clinical Medicine 58: 477.
  • 10 Fisher E. R, Fisher B. 1954; Cytoplasmic liver-cell inclusions following arterialisation in the dog. American Journal of Pathology 30: 987.
  • 11 Gherardi G. J. 1971; Alpha1-antitrypsin deficiency and its effect on the liver. Human Pathology 2: 173.
  • 12 Hallen A, Nilsson I. M. 1964; Coagulation studies in liver disease. Thrombosis et Diathesis haemorrhagica 11: 51.
  • 13 Mallory F. B. 1911; Cirrhosis of the liver. Five different types of lesions from which it may arise. The Johns Hopkins Hospital Bulletin 22: 69.
  • 14 Mallory F. B. 1933; Phosphorus and alcoholic cirrhosis. American Journal of Pathology 9: 557.
  • 15 Marciniak E, Farley C. H, de Simone P. A. 1974; Familial thrombosis due to antithrombin III deficiency. Blood 43: 219.
  • 16 Norkin S. A, Weitzel R, Campagna-Pinto D, MacDonald R. A, Mallory G. K. 1960; “Alcoholic” hyaline in human cirrhosis. Histochemical studies. American Journal of Pathology 37: 49.
  • 17 Norkin S. A, Campagna-Pinto D. 1968; Cytoplasmic hyaline inclusions in hepatoma. A histochemical study. Archives of Pathology 86: 25.
  • 18 Pappenheimer A. M, Hawthorne J. J. 1936; Certain cytoplasmic inclusions of liver cells. American Journal of Pathology 12: 625.
  • 19 Price J. M, Harman J. W, Miller E. C, Miller J. A. 1952; Progressive microscopic alterations in the livers of rats fed the hepatic carcinogens 3’-methyl-4-dimethyl-aminoazobenzene and 4’-fluoro-4-dimethyl-aminoazobenzene. Cancer Research 12: 192.
  • 20 Rosenberg R. D. 1975; Actions and interactions of antithrombin and heparin. New England Journal of Medicine 292: 146.
  • 21 Huang Shao-Nan. 1975; Immunochemical demonstration of Hepatitis B core and Surface antigens in Paraffin Sections. Laboratory Investigation 33: 88.
  • 22 Sharp H. L, Bridges R. A, Krivit W, Freier E. F. 1969; Cirrhosis associated with alpha1-antitrypsin deficiency. A previously unrecognised inherited disorder. Journal of Laboratory and Clinical Medicine 73: 934.
  • 23 Smetana H. F, Hadley G. G, Sirsat S. M. 1961; Infantile cirrhosis. An analytical review of the literature and a report of 50 cases. Pediatrics 28: 107.
  • 24 Travis J, Johnson D, Pannell R. 1974 Properties of alpha1-antitrypsin. In: Inhibitors Bayer-Symposium V. 31.
  • 25 Yin E. T, Wessler S, Stoll P. J. 1971; Idenity of plasma-activated factor X inhibitor with antithrombin III and heparin cofactor. Journal of Biological Chemistry 246: 3712.